Patent details

300770 Product Name: Dimethylfumaraat

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300770
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2801355
Status:
Refused Art. 10 of the EC Regulations
Application number:
300770
Procedural language:
Dutch
First Applicant Residence Country:
Denmark (DK)

Marketing Authorization

Marketing Authorization Number:
EU/1/13/837
Marketing Authorization Type:
EEA
Marketing Authorization Date:
30/01/2014
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
16/11/2015
First Marketing Authorization date:
30/01/2014
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
11/12/2015
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
27/09/2023

Applicant/holder

From:
10/11/2017
 
 

 

Name:
FWP IP APS
Address:
Østergade 24 A 1., 1100, København K, Denmark (DK)

Historical Applicant/holder

From:
10/11/2017
To:
10/11/2017

 

Name:
FORWARD PHARMA OPERATIONS APS
Address:
Østergade 24 A 1., 1100, København K, Denmark (DK)

From:
16/11/2015
To:
10/11/2017

 

Name:
Forward Pharma A/S
Address:
Østergade 24 A 1., 1100 KØBENHAVN K, Denmark (DK)

Agent

Name:
ir. F.A. Geurts c.s.
From:
11/12/2015
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
39/23
Publication date:
27/09/2023
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
04/18
Publication date:
17/01/2018
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
CO
Journal edition number:
04/18
Publication date:
17/01/2018
Description:
Changes in the Netherlands Patent Register

4

Bulletin Heading:
SPC
Journal edition number:
51/15
Publication date:
16/12/2015
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201702213A
Date Registered:
10/11/2017
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
FORWARD PHARMA OPERATIONS APS
Address:
Østergade 24 A 1., 1100, København K, Denmark (DK)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201702213B
Date Registered:
10/11/2017
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
FWP IP APS
Address:
Østergade 24 A 1., 1100, København K, Denmark (DK)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Other

Note:
27 september 2023 - ABC geweigerd omdat het basisoctrooi (na een petition for review) definitief herroepen is
Filing date Document type Document Description Number of pages File Type
27/09/2023 Outgoing Correspondence Decision refusal 1 PDF /6/7/3/9/1/0800019376/docs/300770_15_568399l527a.pdf
20/07/2023 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /6/7/3/9/1/0800019376/docs/300770_14_incomingcorrespondencepaper20230721091124899.pdf
01/03/2022 Outgoing Correspondence Letter to applicant 1 PDF /6/7/3/9/1/0800019376/docs/300770_10_465411l173.pdf
28/02/2022 Incoming Correspondence Paper Incoming Correspondence Paper 2 PDF /6/7/3/9/1/0800019376/docs/300770_3_incomingcorrespondencepaper20220228011755141.pdf
28/02/2022 SPC Documents Annex SPC 17 PDF /6/7/3/9/1/0800019376/docs/300770_9_supplprotectioncertificate20220228011819718.pdf
27/12/2021 Outgoing Correspondence Letter to applicant 1 PDF /6/7/3/9/1/0800019376/docs/300770_4_452283l173.pdf
29/06/2016 Outgoing Correspondence Letter to applicant 3 PDF /6/7/3/9/1/0800019376/docs/300770_13_outgoingcorrespondence20160629095005490.pdf
28/06/2016 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /6/7/3/9/1/0800019376/docs/300770_0_incomingcorrespondencepaper20160629024742232.pdf
28/06/2016 Outgoing Correspondence Outgoing Letter 5 PDF /6/7/3/9/1/0800019376/docs/300770_8_outgoingcorrespondence20160629095121877.pdf
09/05/2016 Incoming Correspondence Paper Incoming correspondence third party 3 PDF /6/7/3/9/1/0800019376/docs/300770_6_incomingcorrespondencepaper20160517094807647.pdf
11/12/2015 Outgoing Correspondence Outgoing Letter 1 PDF /6/7/3/9/1/0800019376/docs/300770_7_21602l174.pdf
16/11/2015 SPC Documents Accompanying letter SPC 1 PDF /6/7/3/9/1/0800019376/docs/300770_1_supplprotectioncertificate20210330035528250.pdf
16/11/2015 SPC Documents Summary of the characteristics of the product 29 PDF /6/7/3/9/1/0800019376/docs/300770_2_supplprotectioncertificate20200409124915303.pdf
16/11/2015 Application Form First filed application form 3 PDF /6/7/3/9/1/0800019376/docs/300770_5_applicationform20151210123837511.pdf
16/11/2015 SPC Documents Marketing Authorization SPC 3 PDF /6/7/3/9/1/0800019376/docs/300770_11_supplprotectioncertificate20200409124115863.pdf
16/11/2015 SPC Documents Annex SPC 1 PDF /6/7/3/9/1/0800019376/docs/300770_12_supplprotectioncertificate20200409124509732.pdf